Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-24-005622
Filing Date
2024-11-13
Accepted
2024-11-13 17:00:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 COWEN AND COMPANY, LLC avdla2_111224.htm SC 13G/A 33907
  Complete submission text file 0001085146-24-005622.txt   35911
Mailing Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022
Business Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022 212-827-6971
COWEN AND COMPANY, LLC (Filed by) CIK: 0000048966 (see all company filings)

EIN.: 841702964 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Subject) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50223 | Film No.: 241455442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)